The diagnostic and prognostic value of serum CXCL12 levels in patients with ischemic stroke

Neurological Sciences

Volumn 36, Issue 12, 2015, Pages 2227-2234

  Duan, Xiao Xia ^a   Zhang, Guan Peng ^b   Wang, Xiao Bin ^a   Yu, Hua ^b   Wu, Jia Li ^a   Liu, Ke Zhi ^b   Wang, Lin ^b   Long, Xiang ^a  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Chinese; CXC chemokine ligand 12; Diagnosis; Marker; Prognostic

Indexed keywords

C REACTIVE PROTEIN; STROMAL CELL DERIVED FACTOR 1; BIOLOGICAL MARKER; CXCL12 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CHINESE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STROKE PATIENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; STROKE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BRAIN ISCHEMIA; CHEMOKINE CXCL12; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84948381991     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2341-8     Document Type: Article

References (35)

1. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F (2004) The global stroke initiative. Lancet Neurol 3:391–393
2. Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4(6):461–470
3. Tu WJ, Dong X, Zhao SJ, Yang DG, Chen H (2013) Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischemic stroke. J Neuroendocrinol 25:771–778
4. Schutt RC, Burdick MD, Strieter RM et al (2012) Plasma CXCL12 levels as a predictor of future stroke. Stroke 43(12):3382–3386
5. Wurster T, Stellos K, Geisler T, Seizer P, Andia ME, Schuster A et al (2012) Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke? Eur J Neurol 19:395–401
6. Li M, Ransohoff RM (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84:116–131
7. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L et al (2006) Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 26:125–134
8. Yu X, Chen D, Zhang Y, Wu X, Huang Z, Zhou H et al (2012) Over-expression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke. J Neurol Sci 316:141–149
9. Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J et al (2011) Stromal-derived factor-1α correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke 42:618–625
10. Paczkowska E, Kucia M, Koziarska D, Halasa M, Safranow K, Masiuk M et al (2009) Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke. Stroke 40:1237–1244
11. Gu XL, Liu L, Lu XD et al (2015) Serum CXCL12 levels as a novel predictor of future stroke recurrence in patients with acute ischemic stroke. Mol Neurobiol (online first)
12. Ruscher K, Kuric E, Liu Y et al (2013) Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab 33(8):1225–1234
13. Kim YS, Baek W, Kim MK et al (2012) Association between serum stromal cell-derived factor-1α and long-term outcome of acute ischemic stroke. Eur Neurol 67(6):363–369
14. Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54:541–553
15. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsanl WG et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870
16. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526
17. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB (1994) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
18. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES (2009) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72:2104–2110
19. Bonita RBR (1988) Modification of Rankin Scale: recovery of motor function after stroke. Stroke 19:1497–1500
20. Jaerve A, Bosse F, Müller HW (2012) SDF-1/CXCL12: its role in spinal cord injury. Int J Biochem Cell Biol 44(3):452–456
21. Kwon HS, Kim YS, Park HH et al (2015) Increased VEGF and decreased SDF-1α in patients with silent brain infarction are associated with better prognosis after first-ever acute lacunar stroke. J Stroke Cereb Dis (online first)
22. Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M et al (2011) A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke. Atherosclerosis 216:205–211
23. Wang Y, Huang J, Li Y et al (2012) Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets 13(2):166–172
24. Petit I, Jin D, Rafii S (2007) The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28:299–307
25. Shin JH, Park YM, Kim DH et al (2014) Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway. Biochim Biophys Acta 1839:826–836
26. Emsley HC, Tyrrell PJ (2002) Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 22:1399–1419
27. Li Y, Tang G, Liu Y et al (2015) Stromal cell-derived factor-1 gene modified endothelial progenitor cell effectively attenuated ischemic brain injury in mouse model. Stroke 46(Suppl 1):A117–A117
28. Ardelt AA, Bhattacharyya BJ, Belmadani A et al (2013) Stromal derived growth factor-1 (CXCL12) modulates synaptic transmission to immature neurons during post-ischemic cerebral repair. Exp Neurol 248:246–253
29. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD (2000) The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86:131–138
30. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858–864
31. Mirabelli-Badenier M, Braunersreuther V, Viviani GL et al (2011) CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 105(3):409
32. Patel JR, McCandless EE, Dorsey D et al (2010) CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 107:11062–11067
33. Hill WD, Hess DC, Martin-Studdard A et al (2004) SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 63(1):84–96
34. Schönemeier B, Schulz S, Hoellt V et al (2008) Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J Neuroimmunol 198(1):39–45
35. Zhao BQ, Tejima E, Lo EH (2007) Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 38:748–752